Search - tctmd.com

Displaying 761 - 780 of 980

Sort: Relevancy | Date

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

Vorapaxar is Safe and Effective and Has an Important Role to Play in Patients with CAD

Presenter: Jessica L. Mega, Daniel I. Simon, Michelle O'Donoghue

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Eric A. Cohen, Dean J. Kereiakes, Stuart Watkins

September 14, 2014

Presentation TCT 2014

Case #3. Multivessel Disease in a Stable CAD Patient

Presenter: Eric A. Cohen, Dean J. Kereiakes, Samer Mansour

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

Case #2: Multivessel Disease in an NSTEMI Patient

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Keith G. Oldroyd

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

September 14, 2014

News Conference News TCT 2014

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

Presentation TCT 2014

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Armando Tellez

September 13, 2014

Presentation TCT 2014

Adult Congenital Heart Disease Interventions: A Changing Panorama

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Jorge Gaspar

September 13, 2014

Advertisement

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Vorapaxar is Safe and Effective and Has an Important Role to Play in Patients with CAD

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #3. Multivessel Disease in a Stable CAD Patient

How Did I Treat This Patient?

Case #2: Multivessel Disease in an NSTEMI Patient

How Did I Treat This Patient?

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

TCT Course Director Outlines Current TAVR Controversies

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

PERFECT-LUTS: Endovascular Revascularization Shows Promise for Patients with ED, Lower Urinary Tract Symptoms

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

Adult Congenital Heart Disease Interventions: A Changing Panorama

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content